Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Because right now, most medspas are, * Launching GLP-1 offers without tightening intake + documentation * Assuming compounding is a free-for-all forever * Marketing outcomes harder than they manage safety * Getting lots of leads and losing most to slow follow-up The truth is, GLP-1 demand is real, but the tolerance for sloppy programs is shrinking
For daily formulations, aligning injection time with your most challenging eating period makes intuitive and pharmacokinetic sense
Ozempic gets the most attention because the name is so widely known
Islam R, et al
Real-World Effectiveness of Tirzepatide versus Semaglutide on HbA1c and Weight in Patients with Type 2 Diabetes
US$ 25.70
US$ 22.58
US$ 23.26
US$ 22.04
US$ 23.55
US$ 27.30
US$ 23.96
US$ 29.65
